John G. Edwards
Vorstandsvorsitzender bei Drusolv Therapeutics, Inc.
Aktive Positionen von John G. Edwards
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Drusolv Therapeutics, Inc.
 Drusolv Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Drusolv Therapeutics, Inc. is an American clinical-stage drug company that is developing a high-dose statin for early intervention in age-related macular degeneration. The CEO of the company is John G. Edwards. | Direktor/Vorstandsmitglied | - | - |
| Vorstandsvorsitzender | - | - |
Karriereverlauf von John G. Edwards
Statistik
International
| Vereinigte Staaten | 2 |
Operativ
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sektoral
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Drusolv Therapeutics, Inc.
Drusolv Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Drusolv Therapeutics, Inc. is an American clinical-stage drug company that is developing a high-dose statin for early intervention in age-related macular degeneration. The CEO of the company is John G. Edwards. | Commercial Services |
- Börse
- Insiders
- John G. Edwards
- Erfahrung
